Last Updated on August 8, 2021 by The Health Master
As the country is ramping up its inoculation drive, the Centre on Tuesday said monthly production capacity of Covishield is projected to be increased to more than 120 million doses and of Covaxin to around 58 million doses by December, citing information from the C-19 vaccine manufacturers.
For the National C-19 vaccination programme, 44.42 crores doses of Covishield and 6.82 crores doses of Covaxin has been supplied by Serum Institute of India (SII) and Bharat Biotech International Limited respectively, from 16th January 2021 to 5th August 2021, informed Union Health Minister Mansukh Mandaviya in Rajya Sabha.
Manufacturers announced plans to increase the production capacity of Covishield from 11 crore doses each month to more than 12 crore doses each month, while the production capacity of Covaxin will increase from 2.5 crore doses per month to around 5.8 crore doses each month.
In a tweet Mandaviya informed about his meeting with CEO AdarPoonawalla, and appreciated the role of SII in mitigating C-19 and also he assured continuous support from government in ramping up of vaccine production.